Patent familyBCI, high confidence
Monolithic, biocompatible feedthrough for hermetically sealed electronics and methods of manufacture
Filed by Neuralink, ニューラリンク コーポレーション and Neuralink Corp, first in 2019.
- Earliest priority
- 12 Jul 2019 · United States
- Status
- A grant was published in European Patent Office, Japan, United States, first on 31 Aug 2021
- Published in
- United States · International (PCT) · South Korea · European Patent Office · Japan
- Registered as
- Neuralink Corp. · 뉴럴링크 코포레이션
- Inventors
- Tolosa, Vanessa M. · Diaz-Botia, Camilo A. · Chen, Supin · Deku, Felix · Huang, Yu Niu · Hettick, Mark J. · and 6 more
- Family
- DOCDB 74103209 · 9 publications
What it concerns
Methods of manufacturing a biocompatible, hermetic feedthrough monolithically integrated with a biocompatible ribbon cable are described, as well as the resulting devices themselves. The hermetic feedthrough is created by placing glass over a mold of doped silicon or other material with a higher melting temperature than the glass and heating it to reflow the glass into the mold. The glass is then ground or otherwise removed to reveal a flat surface, and tiny pillars that were in the mold are isolated in the glass to form electrically conductive vias. The flat surface is used to cast a polymer and build up a ribbon cable, photolithographically or otherwise, that is monolithically attached to the vias.
The abstract as published by the patent office, from US2021013051A1. It describes the invention; it is not a statement of what is protected.
Protection themes
Interface and electrodes
Electrodes and arrays
Implant electronics
Chips and on-implant computing
Packaging
Packaging and hermeticity · Connectors and feedthroughs
Stimulation
Stimulation
What the filing appears to be about, read by published rules from its title, abstract and classification codes (A61N1/0531, A61N1/3605, A61N1/3754, A61N1/3758, B81B2201/036). The claims define what a patent protects, and they are not read here.
Why it matters
- Interface and electrodes
- Everything downstream works with what the contacts pick up. Their number, size and distance from the neurons set the ceiling on the signal. The problem behind it: more contacts, closer to neurons, that still record after years in tissue that reacts to them.
- Implant electronics
- An implant has room for very little, so functions that fill a rack in the laboratory have to fit on a chip. The problem behind it: fitting channel count, computing and safety functions into a volume and a heat budget the body accepts.
- Packaging
- Body fluid destroys unprotected electronics. An implant meant to last has to stay sealed for years while passing every channel through its wall. The problem behind it: a seal that lasts as long as the patient needs it, at a size that leaves room for the channels.
Why the layer matters to the field, not a judgement of this filing. A patent family shows that protection was sought. It does not show that the technology was built, is used in a product, or works in people. The whole stack
The family
One invention, published 9 times in 5 offices. Each publication opens in Espacenet.
- United StatesUS2021013051A114 Jan 2021US11107703B231 Aug 2021 · grant
- International (PCT)a route to several countries, not a countryWO2021011298A121 Jan 2021
- South KoreaKR20220035406A22 Mar 2022
- European Patent Officea route to several countries, not a countryEP3997045A118 May 2022EP3997045A426 Oct 2022EP3997045B116 Apr 2025 · grant
- JapanJP2022540836A20 Sep 2022JP7590402B226 Nov 2024 · grant
Timeline
- 12 Jul 2019First filingEarliest priority, at United States. The family is counted in this year.
- 9 Jul 2020ApplicationsFiled at United States, International (PCT), South Korea, European Patent Office, Japan.
- 9 Jul 2020Owner recordedUnited States, on US2021013051A1: assignment; owner named: NEURALINK CORP., CALIFORNIA.
- 14 Jan 2021First publicationUS2021013051A1, United States.
- 31 Aug 2021Grant publishedUS11107703B2, United States.
- 2 Jul 2024Office recordJapan, on JP2022540836A: notification of reasons for refusal.
- 26 Nov 2024Grant publishedJP7590402B2, Japan.
- 16 Apr 2025Grant publishedEP3997045B1, European Patent Office.
- 26 Aug 2026Office recordEuropean Patent Office, on EP3997045A1: lapsed in a contracting state [announced via postgrant information from national office to epo] (AT, BE, BG, CH, CY, CZ, DK, EE, ES, FI, GR, HR, IE, IS, IT, LT, LU, LV, MC, NL, NO, PL, PT, RO, RS, SE, SK, SM, TR).
Dates as the offices published them. Office records are in the offices' own words and are a selection: refusals, lapses and withdrawals, and records that name an owner. Each concerns one member of the family, not the family as a whole, and another member in the same office may stand. Whether a patent is in force today is not assessed.
Sources
- Bibliographic data, family members and office records: European Patent Office, Open Patent Services (the DOCDB and INPADOC databases), read 7 Oct 2026.
- The record itself, with its claims and description: US2021013051A1 in Espacenet
- Counted as a BCI patent family: classified A61N1/0531 (brain cortex electrodes); filed by Neuralink Corp., an organisation already in the graph; a hardware layer of the stack, filed by a company that builds interfaces; cites a family already accepted. How families are found and judged